Set the Standard in Clinical NGS Sample QC
Generate reliable, traceable, and audit-ready DNA and RNA sample QC results with CE-IVD-labeled systems and software that support regulated workflows.
Behind every sample is a patient waiting for answers. TapeStationDx systems help reduce sequencing failure risk and minimize repeat runs through reliable nucleic acid sample QC.
Generate traceable, audit-ready DNA and RNA QC results supporting IVDR, 21 CFR Part 11, and EU Annex 11 requirements.
Streamline sample QC with easy, automated workflows for consistent operation and confident pass/fail decisions.
Generate results in as little as 1–2 minutes per sample while maintaining flexible throughput and a constant cost per sample.
Achieve reliable DNA and RNA QC results with just 1–2 µL of sample input, even in high-sensitivity applications.
Everything you need in one package
Download the portfolio brochure, system and software data sheets, and the Support for 21 CFR Part 11, Annex 11, and IVD Data Integrity Compliance white paper.
The TapeStationDx systems are automated electrophoresis solutions that combine CE-IVD-labeled instruments and software. From low to high throughput, select the system that best fits your laboratory's needs.
Optimized for lower-throughput laboratories with a compact footprint. Process up to 16 samples per run.
Designed for flexible throughput and growing sample volumes. Process 1–96 samples per run with scalable loading options.
Bundled with the TapeStationDx systems. Designed to protect data integrity from sample to report in regulated labs.
Whether you're evaluating a new system or planning an upgrade, an Agilent specialist can help you identify the right TapeStationDx system for your laboratory and discuss available trade-in opportunities for eligible systems.
Complete the form below to access the resource kit or speak with an Agilent specialist.
*Available in the United States, Canada, and selected Western European countries. Contact your local Agilent representative for details.
For In Vitro Diagnostic Use.
D0151876 Revision A.00